Supplementary Material and Methods from Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells

MLA

Ramon Alemany, et al. Supplementary Material and Methods from Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22505149.

APA

Ramon Alemany, Javier García-Castro, Ahmed Abdullah Al-Zaher, Alvaro Morales-Molina, Ana Judith Perisé-Barrios, Marti Farrera-Sal, Carlos Alberto Fajardo, & Rafael Moreno. (2023). Supplementary Material and Methods from Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells. https://doi.org/10.1158/1535-7163.22505149

Chicago

Ramon Alemany, Javier García-Castro, Ahmed Abdullah Al-Zaher, Alvaro Morales-Molina, Ana Judith Perisé-Barrios, Marti Farrera-Sal, Carlos Alberto Fajardo, and Rafael Moreno. 2023. “Supplementary Material and Methods from Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells,” April. doi:10.1158/1535-7163.22505149.